Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 16th October 2018
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Dopharma to acquire Boehringer Ingelheim production site
The move follows the presentation of Boehringer’s animal health strategic orientations.

Sale of Saint-Herblon site expected to complete in early 2019

Boehringer Ingelheim has announced the sale of its production site in Saint-Herblon, France, to Dutch company Dopharma.

First announced in October last year, the move follows the presentation of Boehringer’s animal health strategic orientations.

The group confirmed its strategy to focus on advanced and preventative healthcare; Saint-Herblon mainly produces generics and antibiotics for livestock.

Dopharma is an independent, family-owned company that develops, produces and distributes veterinary products for livestock.

Erick Lelouche, president of Boehringer Ingelheim Animal Health in France, said: “I am convinced that this project will offer a solid foundation for the future to the site and its employees. Indeed, we will collaborate with Dopharma Saint-Herblon that will produce some of our specialized products during the coming years.”

The sale is expected to complete by the end of the first quarter of 2019, after the legal and consultation process is finalised.

Become a member or log in to add this story to your CPD history

SPVS and FIVP launch VSA survey

News Story 1
 SPVS and FIVP have collaborated to launch a short survey about the proposed reform of the Veterinary Surgeons Act.

The survey will ensure that each organisation's submission accurately represents the experiences of practising veterinary professionals. It will also explore awareness, use and perceived value of the roles undertaken by the RCVS.

It takes around 5-10 minutes to complete, and all responses are anonymous. The survey can be completed here until Thursday, 19 March 2026. 

Click here for more...
News Shorts
RCVS annual renewal fee for vets due

RCVS' annual renewal fee for veterinary surgeons is now due. Vets must pay their renewal fee before Wednesday, 1 April 2026.

This year's standard annual fee has increased to 431 from last year's 418. This is an approximately three per cent increase, as approved by RCVS Council and the Privy Council.

Tshidi Gardner, RCVS treasurer, said: "The small fee increase will be used to help deliver both our everyday activities and our new ambitious Strategic Plan, which includes aims such as achieving new legislation, reviewing the Codes of Professional Conduct and supporting guidance, and continuing to support the professions through activities such as the Mind Matters Initiative, RCVS Academy and career development."

A full breakdown of the new fees is on the RCVS website. Information about tax relief is available on the UK government website.